Delayed antibiotics prescription in uncomplicated UTI tied to poorer outcomes in females: Study

Written By :  Dr. Hiral patel
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-07-10 14:30 GMT   |   Update On 2022-07-10 14:30 GMT
Advertisement

Germany: When compared to immediate antibiotics, non-antibiotic strategies helped to reduce overall antibiotic use but resulted in poorer clinical outcomes in women with uncomplicated urinary tract infections (uUTI), states an article published in Clinical Microbiology and Infection.

Urinary tract infections (UTIs) are among the most common types of bacterial infections in clinical medicine. Cystitis and pyelonephritis are considered uncomplicated urinary tract infections (uUTI) in women with structurally and functionally normal urinary tract. Antibiotics are usually the first-line treatment in such patients. Though self-limiting in many cases, UTI accounts for a significant number of antibiotic prescriptions and leads to antibiotic resistance.

Advertisement

Rising rates of antibiotic resistance and a better understanding of the ecological adverse effects (collateral damage) of antibiotics warrant a reevaluation of antibiotics for treating uncomplicated UTIs. Various Randomised controlled trials (RCTs) have investigated analgesics, herbal formulations, delayed prescription of antibiotics, and placebo to curb over-prescription of antibiotics in women with uUTI. 

Kaußner Y, University Medical Center Wuerzburg, Germany, and colleagues conducted a study to estimate the effect of experimental strategies on symptoms, antibiotic use, and incidence of complications (specifically pyelonephritis and febrile UTI) and to identify symptoms, signs, or other factors that indicate a benefit from these strategies.

Researchers performed a literature search in MEDLINE, EMBASE, Web of Science, LILACS, Cochrane Database of Systematic Reviews and Controlled Trials, and ClinicalTrials. RCTs investigating immediate antibiotics versus any alternate strategies to reduce antibiotics in adult women with uUTI in primary care were included in the study. Individual participant data (IPD) was extracted if available, otherwise, aggregate data (AD) was used for data synthesis. Bayesian random-effects meta-analysis of the AD was used for pairwise comparisons. Candidate moderators and prognostic indicators of treatment effects were investigated using generalized linear mixed models based on IPD. Researchers analyzed the IPD of 3524 patients from eight RCTs and AD of 78 patients

Key findings of the review,

• Non-antibiotic strategies increased the rates of incomplete recovery (Bayesian p-value pB=0.0017), subsequent antibiotic treatment(pB=0.0003) and pyelonephritis ( pB=0.0003).

• Non-antibiotic strategies decreased the overall use of antibiotics by 63%.

• Patients with erythrocytes in urine and positive urine cultures were at increased risk of incomplete recovery (pB =0.0010), but no difference was apparent when both were negative (pB =0.667).

• In patients, treated with non-antibiotic strategies, urinary erythrocytes and positive urine culture were independent prognostic indicators for subsequent antibiotic treatment and pyelonephritis.

The researchers conclude that compared to immediate antibiotics, non-antibiotic strategies reduce overall antibiotic use but result in poorer clinical outcomes in women with uUTI. The presence of erythrocytes and tests to confirm bacteria in urine could be used to target antibiotic prescribing.

Reference: 

Kaußner Y, Röver C, Heinz J, Hummers E, Debray TPA, Hay AD, Heytens S, Vik I, Little P, Moore M, Stuart B, Wagenlehner F, Kronenberg A, Ferry S, Monsen T, Lindbæk M, Friede T, Gágyor I. Reducing antibiotic use in uncomplicated urinary tract infections in adult women: a systematic review and individual participant data meta-analysis. Clin Microbiol Infect. 2022 Jul 1:S1198-743X(22)00330-5. doi: 10.1016/j.cmi.2022.06.017. Epub ahead of print. PMID: 35788049.

Tags:    
Article Source : Clinical Microbiology and Infection

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News